Drug Profile
PRA 027
Alternative Names: PRA-027; WAY-257027Latest Information Update: 29 Sep 2010
Price :
$50
*
At a glance
- Originator Wyeth
- Developer Pfizer
- Class Antineoplastics; Benzonitrile; Oxazolidinones; Small molecules; Thiazoles
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Uterine leiomyoma